Smart biomaterials for enhancing cancer therapy by overcoming tumor hypoxia: a review
- PMID: 36505711
- PMCID: PMC9693911
- DOI: 10.1039/d2ra06036a
Smart biomaterials for enhancing cancer therapy by overcoming tumor hypoxia: a review
Abstract
Hypoxia is a distinctive feature of most solid tumors due to insufficient oxygen supply of the abnormal vasculature, which cannot work with the demands of the fast proliferation of cancer cells. One of the main obstacles to limiting the efficacy of cancer medicines is tumor hypoxia. Thus, oxygen is a vital parameter for controlling the efficacy of different types of cancer therapy, such as chemotherapy (CT), photodynamic therapy (PDT), photothermal therapy (PTT), immunotherapy (IT), and radiotherapy (RT). Numerous technologies have attracted much attention for enhancing oxygen distribution in humans and improving the efficacy of cancer treatment. Such technologies include treatment with hyperbaric oxygen therapy (HBO), delivering oxygen by polysaccharides (e.g., cellulose, gelatin, alginate, and silk) and other biocompatible synthetic polymers (e.g., PMMA, PLA, PVA, PVP and PCL), decreasing oxygen consumption, producing oxygen in situ in tumors, and using polymeric systems as oxygen carriers. Herein, this review provides an overview of the relationship between hypoxia in tumor cells and its role in the limitation of different cancer therapies alongside the numerous strategies for oxygen delivery using polysaccharides and other biomaterials as carriers and for oxygen generation.
This journal is © The Royal Society of Chemistry.
Conflict of interest statement
The authors report no conflicts of interest in this work.
Figures








Similar articles
-
Recent Strategies to Address Hypoxic Tumor Environments in Photodynamic Therapy.Pharmaceutics. 2022 Aug 24;14(9):1763. doi: 10.3390/pharmaceutics14091763. Pharmaceutics. 2022. PMID: 36145513 Free PMC article. Review.
-
Oxygen-producing catalase-based prodrug nanoparticles overcoming resistance in hypoxia-mediated chemo-photodynamic therapy.Acta Biomater. 2020 Aug;112:234-249. doi: 10.1016/j.actbio.2020.05.035. Epub 2020 Jun 2. Acta Biomater. 2020. PMID: 32502633
-
Conquering the Hypoxia Limitation for Photodynamic Therapy.Adv Mater. 2021 Dec;33(48):e2103978. doi: 10.1002/adma.202103978. Epub 2021 Sep 27. Adv Mater. 2021. PMID: 34580926 Review.
-
Modulating Hypoxia via Nanomaterials Chemistry for Efficient Treatment of Solid Tumors.Acc Chem Res. 2018 Oct 16;51(10):2502-2511. doi: 10.1021/acs.accounts.8b00214. Epub 2018 Sep 20. Acc Chem Res. 2018. PMID: 30234960
-
Biogenic nanobubbles for effective oxygen delivery and enhanced photodynamic therapy of cancer.Acta Biomater. 2020 May;108:313-325. doi: 10.1016/j.actbio.2020.03.034. Epub 2020 Apr 5. Acta Biomater. 2020. PMID: 32268236
Cited by
-
Photosynthetic Bacteria: Light-Responsive Biomaterials for Anti-Tumor Photodynamic Therapy.Int J Nanomedicine. 2025 Jan 10;20:465-482. doi: 10.2147/IJN.S500314. eCollection 2025. Int J Nanomedicine. 2025. PMID: 39811429 Free PMC article. Review.
-
Highways and Detours in the Realm of Photodynamic Therapy.Int J Mol Sci. 2024 Mar 8;25(6):3119. doi: 10.3390/ijms25063119. Int J Mol Sci. 2024. PMID: 38542092 Free PMC article. Review.
-
Precision Nanomedicine with Bio-Inspired Nanosystems: Recent Trends and Challenges in Mesenchymal Stem Cells Membrane-Coated Bioengineered Nanocarriers in Targeted Nanotherapeutics.J Xenobiot. 2024 Jun 24;14(3):827-872. doi: 10.3390/jox14030047. J Xenobiot. 2024. PMID: 39051343 Free PMC article. Review.
References
-
- Salim S. A. Kamoun E. A. Evans S. Taha T. H. El-Fakharany E. M. Elmazar M. M. Abdel-Aziz A. F. Abou-Saleh R. H. Salaheldin T. A. Novel Oxygen-Generation from Electrospun Nanofibrous Scaffolds with Anticancer Properties: Synthesis of PMMA-Conjugate PVP–H2O2 Nanofibers, Characterization, and in Vitro Bio-Evaluation Tests. RSC Adv. 2021;11(33):19978–19991. - PMC - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Miscellaneous